Calan SR en es it fr

Calan SR Brand names, Calan SR Analogs

Calan SR Brand Names Mixture

  • Tarka (trandolapril + verapamil hydrochloride)

Calan SR Chemical_Formula

C27H38N2O4

Calan SR RX_link

http://www.rxlist.com/cgi/generic/verapsr.htm

Calan SR fda sheet

Calan_SR FDA

Calan SR msds (material safety sheet)

Calan SR Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Calan SR Molecular Weight

454.602 g/mol

Calan SR Melting Point

< 25 oC

Calan SR H2O Solubility

4.47 mg/L

Calan SR State

Liquid

Calan SR LogP

5.931

Calan SR Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Calan SR Indication

For the treatment of hypertension and angina.

Calan SR Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Calan SR Absorption

90%

Calan SR side effects and Toxicity

LD50=8 mg/kg (i.v. in mice)

Calan SR Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Calan SR Organisms Affected

Humans and other mammals